XWELNasdaqServices-Personal ServicesFiscal year ends December 31
XWELL, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.72−0.02 (-2.38%)
Close on Oct 19, 2026
- Market cap
- $6.08M
- P/E (TTM)
- –
- Dividend yield
- –
XWELL, Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XpresSpa | $17.84M | $18.55M | $18.65M | $18.56M | $18.59M | $18.63M | $18.77M | $18.59M | $18.70M | $19.00M | $19.07M | $18.87M | 63.1% | -4.0% |
| XpresTest | $8.31M | $7.99M | $8.25M | $8.79M | $9.90M | $11.59M | $13.06M | $13.00M | $12.18M | $11.20M | $9.91M | $10.63M | 29.4% | -16.1% |
| Naples Wax | $2.14M | $2.28M | $2.31M | $2.18M | $2.11M | $1.98M | $2.08M | – | – | – | – | – | 7.6% | +1.4% |
| Treat | – | – | – | – | – | – | $430.00K | – | – | – | – | $765.00K | – | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XpresTest | $5.61M | $4.76M | $4.31M | $4.51M | $3.19M | $4.14M | $5.19M | $4.82M | -$1.59M | -$2.75M | -$4.70M | -$5.66M | +75.9% |
| XpresSpa | -$2.05M | -$1.43M | -$40.00K | -$4.66M | -$6.70M | -$8.72M | -$12.30M | -$10.63M | -$11.22M | -$12.60M | -$12.95M | -$12.89M | -69.4% |
| Naples Wax | -$4.75M | -$5.37M | -$5.85M | -$1.37M | -$1.05M | -$837.00K | -$496.00K | – | – | – | – | – | +354.1% |
| Corporate and other | -$16.14M | -$15.88M | -$14.10M | -$12.77M | -$13.73M | -$12.07M | -$9.10M | -$8.39M | -$7.20M | -$7.16M | -$8.40M | -$8.92M | +17.6% |
| Treat | – | – | – | – | – | – | $15.00K | $113.00K | -$1.55M | -$2.54M | -$2.32M | -$8.93M | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Services | $25.54M | $25.91M | $26.27M | $26.54M | $27.55M | $29.04M | $30.66M | $30.60M | $29.84M | $28.91M | $27.34M | $26.55M | 90.3% | -7.3% |
| Products | $2.74M | $2.91M | $2.94M | $2.98M | $3.05M | $3.15M | $3.24M | $3.23M | $3.04M | $2.86M | $2.77M | $2.67M | 9.7% | -10.2% |
| Other | – | – | – | – | – | – | – | – | – | – | $40.00K | $31.00K | – | – |
| Patient services revenue | – | – | – | – | – | – | – | – | – | – | $250.00K | $1.20M | – | – |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $22.81M | $23.07M | $23.42M | $23.63M | $24.60M | $26.17M | $27.81M | – | – | – | – | – | 80.7% | -7.3% |
| All other countries | $5.47M | $5.75M | $5.79M | $5.89M | $6.00M | $6.02M | $6.08M | – | – | – | – | – | 19.3% | -8.8% |
From the segment and revenue-disaggregation notes of Xwell's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.